Clinical Trial 13933

Fort Lauderdale, FL 33351

Study Summary:

The purpose of this study is to evaluate the safety, tolerability and effectiveness of DS-5565 compared to placebo (inactive substance) and pregabalin in diabetic subjects with DPN.

Qualified Participants Must:

• Be 18 years of age or older
• Have a diagnosis of Type 1 or 2 diabetes mellitus for at least 1 year
• Have daily pain attributed to diabetic neuorpathy for at least 3 months prior to screening

Qualified Participants May Receive:

All study-related medical care and compensation for time and travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.